![Kleem Chaudhary](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kleem Chaudhary
Corporate Officer/Principal presso
CHECKMATE PHARMACEUTICALS, INC.
Profilo
Kleem Chaudhary is currently President, Chief Executive Officer & Director at Hyku Biosciences, Inc. since 2024.
Dr. Chaudhary is Chief Business Officer at Checkmate Pharmaceuticals, Inc. since 2019.
Dr. Chaudhary is Chief Operating Officer at Redona Therapeutics, Inc. Formerly, Dr. Chaudhary was Director-Oncology Division at Novartis AG from 2009 to 2016.
Dr. Chaudhary was Senior Director-Business Development & Licensing at Takeda Pharmaceutical Co., Ltd. from 2016 to 2018.
Dr. Chaudhary was Head-Business Development & Licensing at Biogen, Inc. from 2018 to 2019.
Dr. Chaudhary earned a doctorate from The University of North Carolina at Chapel Hill and an undergraduate degree from The University of Winnipeg.
Posizioni attive di Kleem Chaudhary
| Società | Posizione | Inizio |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2019 |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Direttore operativo | - |
Precedenti posizioni note di Kleem Chaudhary
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/10/2019 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/01/2018 |
| NOVARTIS AG | Corporate Officer/Principal | 01/05/2016 |
Formazione di Kleem Chaudhary
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Winnipeg
 The University of Winnipeg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
